JP2022527084A5 - - Google Patents
Info
- Publication number
- JP2022527084A5 JP2022527084A5 JP2021557383A JP2021557383A JP2022527084A5 JP 2022527084 A5 JP2022527084 A5 JP 2022527084A5 JP 2021557383 A JP2021557383 A JP 2021557383A JP 2021557383 A JP2021557383 A JP 2021557383A JP 2022527084 A5 JP2022527084 A5 JP 2022527084A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- heavy chain
- light chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962825983P | 2019-03-29 | 2019-03-29 | |
| US62/825,983 | 2019-03-29 | ||
| PCT/US2020/025181 WO2020205499A1 (en) | 2019-03-29 | 2020-03-27 | Engineered variant antibodies that bind cd38 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022527084A JP2022527084A (ja) | 2022-05-30 |
| JP2022527084A5 true JP2022527084A5 (https=) | 2023-02-16 |
| JP7555953B2 JP7555953B2 (ja) | 2024-09-25 |
Family
ID=72666916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557383A Active JP7555953B2 (ja) | 2019-03-29 | 2020-03-27 | Ｃｄ３８に結合する操作されたバリアント抗体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20220144966A1 (https=) |
| EP (1) | EP3947465A4 (https=) |
| JP (1) | JP7555953B2 (https=) |
| CN (2) | CN114524877A (https=) |
| CA (1) | CA3134612A1 (https=) |
| WO (1) | WO2020205499A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3103114A1 (en) * | 2018-06-20 | 2019-12-26 | Sorrento Therapeutics, Inc. | Variant antibody that binds cd38 |
| CN114516918B (zh) * | 2022-03-04 | 2022-09-27 | 四川大学华西医院 | 一种抗体及其应用 |
| CN114409788B (zh) * | 2022-03-04 | 2022-10-04 | 四川大学华西医院 | 抗cd38的抗体及其应用 |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| CN120607617A (zh) * | 2024-03-07 | 2025-09-09 | 宜明昂科生物医药技术（上海）股份有限公司 | 靶向cd38和cd47的重组融合蛋白 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005049802A2 (en) * | 2003-11-14 | 2005-06-02 | Massachusetts Institute Of Technology | Anti-hydroxylase antibodies and uses thereof |
| JP5225069B2 (ja) | 2005-03-23 | 2013-07-03 | ゲンマブ エー／エス | 多発性骨髄腫の治療のためのｃｄ３８に対する抗体 |
| US20090258005A1 (en) * | 2007-05-29 | 2009-10-15 | Trubion Pharmaceuticals Inc. | Therapeutic compositions and methods |
| JOP20210044A1 (ar) | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| GB201503812D0 (en) * | 2015-03-06 | 2015-04-22 | Univ Aberdeen | Antibody molecules and uses thereof |
| US9951144B2 (en) | 2015-04-08 | 2018-04-24 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind CD38 |
| US11124806B2 (en) * | 2015-11-17 | 2021-09-21 | Global Bioenergies | Methods for producing isobutene from 3-methylcrotonic acid |
| CN110997722B (zh) * | 2017-06-08 | 2023-09-26 | 黑带医疗有限公司 | Cd38调节抗体 |
| EP3641831B1 (en) | 2017-06-20 | 2024-11-06 | Sorrento Therapeutics, Inc. | Cd38 antibody drug conjugate |
| CA3103114A1 (en) * | 2018-06-20 | 2019-12-26 | Sorrento Therapeutics, Inc. | Variant antibody that binds cd38 |
-
2020
- 2020-03-27 CA CA3134612A patent/CA3134612A1/en active Pending
- 2020-03-27 EP EP20784030.7A patent/EP3947465A4/en not_active Withdrawn
- 2020-03-27 CN CN202210168939.3A patent/CN114524877A/zh active Pending
- 2020-03-27 JP JP2021557383A patent/JP7555953B2/ja active Active
- 2020-03-27 US US17/599,377 patent/US20220144966A1/en not_active Abandoned
- 2020-03-27 CN CN202080040061.4A patent/CN113939537A/zh active Pending
- 2020-03-27 WO PCT/US2020/025181 patent/WO2020205499A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7273101B2 (ja) | Ｃｄ３８に結合する抗体治療剤 | |
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2022527084A5 (https=) | ||
| CN111670203B (zh) | 双特异性抗体 | |
| JP2022521956A5 (https=) | ||
| WO2018137576A1 (zh) | 抗pd-1单克隆抗体及其制备方法和应用 | |
| WO2018113258A1 (zh) | 抗pd-1抗体及其用途 | |
| CN107922484A (zh) | 结合tim3的抗体治疗剂 | |
| JP7688805B2 (ja) | 二重特異性抗体 | |
| TW202146451A (zh) | 抗人類cd19抗體 | |
| US20250206820A1 (en) | Ilt3 and cd3 binding agents and methods of use thereof | |
| JP2023179541A (ja) | Ｃｄ３結合分子 | |
| JP2022120846A (ja) | ヒトｐｄ－ｌ１に結合する抗体 | |
| JP7574692B2 (ja) | 二重特異性抗体 | |
| JP2023532248A (ja) | 免疫関連疾患のためのｔｉｇｉｔに対するヒトモノクローナル抗体 | |
| AU2020272376B2 (en) | Bispecific antibody specifically binding to GPNMB and CD3, and use thereof | |
| WO2023186112A1 (zh) | 靶向ceacam和cd3的多特异性抗体及其用途 | |
| RU2021128015A (ru) | Антигенсвязывающие белки, которые связываются с bcma | |
| US20250376531A9 (en) | Anti-4-1bb antibodies and methods of making and using thereof | |
| JP7714992B2 (ja) | 二重特異性抗体を有効成分として含む医薬組成物 | |
| EP4603509A1 (en) | Multifunctional recombinant antibody, and preparation method and use therefor | |
| KR20260062933A (ko) | 항-γδ TCR 항체 및 이의 용도 | |
| HK40062297A (en) | Bispecific antibody | |
| HK40062297B (zh) | 双特异性抗体 |